InsidersTradesSigma
엔지켐생명과학: insider trades · South Korea · DART (FSS)
DART:company-3c7875KR·DART (FSS)Mcap 76.2Bn€Healthcare
Discover the full management transaction log of 엔지켐생명과학, a listed issuer based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, 엔지켐생명과학 has published 3 public disclosures. Market capitalisation: €76.2bn. The latest transaction was reported on 7 April 2026 — Purchase. Among the most active insiders: 브리짓라이프사이언스. All data is free.
3
Insider Decl.
0
Thresholds
€5m
2 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
990.00 €
Analyst consensus
Income statement
Revenue67.75 Bn€
Gross profit3.38 Bn€5% margin
Net income−18.13 Bn€-36.1% margin
Balance sheet & cash
Market cap76.24 Bn€
Total debt4.84 Bn€
Free Cash Flow−11.79 Bn€
Debt / Equity3%
Profitability & ownership
% insiders13.1%
% institutions0.8%
Last declaration on 7 April 2026
Declarations3 total
Executives●Purchase3DART
€4,0637,200 shares
KRX
DART:20260407003461·
Ideal exit: 2 Jan 2027 (T+270)
3 of 3 declarations